Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginReturn on AssetsReturn on Capital EmployedReturn on Sales

ProQR Therapeutics N.V (PRQR) Equity Ratio: 2021-2024

Historic Equity Ratio for ProQR Therapeutics N.V (PRQR) over the last 1 years, with Dec 2024 value amounting to 527.27.

  • ProQR Therapeutics N.V's Equity Ratio rose 175551.64% to 527.27 in Q4 2024 from the same period last year, while for Dec 2024 it was 527.27, marking a year-over-year increase of 175551.64%. This contributed to the annual value of 0.53 for FY2024, which is 75.65% up from last year.
  • ProQR Therapeutics N.V's Equity Ratio amounted to 527.27 in Q4 2024, which was up 175,551.64% from 0.30 recorded in Q4 2023.
  • In the past 5 years, ProQR Therapeutics N.V's Equity Ratio registered a high of 598.52 during Q1 2021, and its lowest value of 0.30 during Q4 2023.
  • For the 3-year period, ProQR Therapeutics N.V's Equity Ratio averaged around 132.09, with its median value being 0.39 (2022).
  • Its Equity Ratio has fluctuated over the past 5 years, first tumbled by 99.93% in 2022, then surged by 175,551.64% in 2024.
  • Quarterly analysis of 4 years shows ProQR Therapeutics N.V's Equity Ratio stood at 0.54 in 2021, then dropped by 28.51% to 0.39 in 2022, then declined by 22.88% to 0.30 in 2023, then spiked by 175,551.64% to 527.27 in 2024.
  • Its Equity Ratio stands at 527.27 for Q4 2024, versus 0.30 for Q4 2023 and 0.39 for Q4 2022.